BioAge Labs, Inc. begins Phase 2 trial for obesity and cardiovascular risk treatment

Traders Union
All News
Business & Wealth
Companies
BioAge Labs, Inc. starts key trial

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Business & Wealth

Market Voices

Ivan Andriyenko

10.07.2026

BioAge Labs, Inc. begins Phase 2 trial for obesity and cardiovascular risk treatment — BioAge Labs, Inc. starts key trial

BioAge Labs, Inc. has launched QUELL-CV, a Phase 2 clinical study testing its oral NLRP3 inhibitor BGE-102 in adults with obesity and heightened cardiovascular risk.

The move highlights BioAge Labs, Inc.’s strategy of advancing novel therapeutics for challenging metabolic and cardiovascular diseases. A second trial evaluating BGE-102 in diabetic macular edema is set to start later this year, marking the company’s continued expansion into proof-of-concept studies in related indications.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

BioAge Labs has recently increased its visibility through initiatives beyond clinical trials. The company published a new BioAge Podcast episode exploring advances in longevity science and healthspan extension drugs. This content highlights ongoing efforts to engage the scientific community and promote research updates.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

#BioAge Labs

Editor's Picks for You

France's crypto market matures as regulation reshapes the industry

By Olena Litvinenko
11 hours ago

France's crypto market matures as regulation reshapes the industry

Editors' Picks

SK Hynix’s rise reshapes the global chip industry and economy

By Dmytro Kharkov
14 hours ago

SK Hynix’s rise reshapes the global chip industry and economy

Editors' Picks

Binance hack: The biggest theft in crypto history

By Eugene Komchuk
16 hours ago

Binance hack: The biggest theft in crypto history

Editors' Picks

All Editors' Top Picks

Latest BioAge Labs News

DeepOriginBio partnership accelerates BioAge Labs progress on human aging drug discovery

By Igor Krasulya
15.10.2026

DeepOriginBio partnership accelerates BioAge Labs progress on human aging drug discovery

Companies

BioAge Labs presents oral NLRP3 inhibition research on reversing aging effects in mice

By Mykhailo Ihnatenko
28.09.2026

BioAge Labs presents oral NLRP3 inhibition research on reversing aging effects in mice

Companies

Inflammation found to underlie cardiology, oncology, and other key fields as BioAge Labs, Inc. advances research

By Andreas Kristo
30.07.2026

Inflammation found to underlie cardiology, oncology, and other key fields as BioAge Labs, Inc. advances research

Companies

All BioAge Labs News

Olena Litvinenko
11 hours ago

France's crypto market matures as regulation reshapes the industry

Dmytro Kharkov
14 hours ago

SK Hynix’s rise reshapes the global chip industry and economy

Eugene Komchuk
16 hours ago

Binance hack: The biggest theft in crypto history

Ksenia Gerey
Yesterday

From PlayStation to crypto: Why Sony is building its own blockchain

Oleg Tkachenko
Yesterday

Google loses billions: What’s behind Alphabet’s stock crash?

Mikhail Vnuchkov
5 min ago

Nik Bhatia: Bitcoin drops after Binance hack, Nasdaq faces key breakdown

Mykhailo Ihnatenko
15 min ago

Fred Krueger: U.S. debt nears $41 trillion ahead of Thanksgiving

Pavlo Kot
30 min ago

Michael Shellenberger: Australia lost billions on renewable hydrogen as major miner faces cuts

Daria Chernytska
45 min ago

Tim Pool: Stock market plunges ahead of U.S. midterm elections, GOP faces potential losses

Yulia Slavina
45 min ago

Administration faces over 50 percent drop from all-time high, Guy Adami notes

Top News

Olga Shendetskaya
9 hours ago

Oil prices jump as tanker attack threatens Strait of Hormuz shipments

Oil prices jump as tanker attack threatens Strait of Hormuz shipments

Eugene Komchuk
10 hours ago

Wall Street expects crypto market to recover quickly from Binance hack

Wall Street expects crypto market to recover quickly from Binance hack

Igor Krasulya
11 hours ago

Nasdaq-100 futures tumble as AI spending worries hit tech stocks

Nasdaq-100 futures tumble as AI spending worries hit tech stocks

Parshwa Turakhiya
14 hours ago

Trezor warns of possible crypto wallet implant linked to CryptoBilis

Trezor warns of possible crypto wallet implant linked to CryptoBilis

Dmytro Kharkov
14 hours ago

SK Hynix’s rise reshapes the global chip industry and economy

SK Hynix’s rise reshapes the global chip industry and economy

Top 5 companies for you

United States

Live News

Andrey Mastykin
Now

Eurozone economy slows as France slips into recession fears

Anton Kharitonov
Now

EUR/USD recovery stalls near 1.1210 as dollar retains its fundamental advantage

Anastasiia Chabaniuk
Now

Binance launches stolen asset recovery and allocates $6.34 billion to cover losses

Mykhailo Ihnatenko
Now

AMD stock drops over 7% as Intel outlook hits semiconductor sentiment

Jose Antonio Gastelum
Now

Circle phases out old USDC bridge as CCTP V2 takes over

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.